📰 Exact Sciences News
Page 24 - Exact Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences. Real-time updates on events, politics, business and more.
November 3, 2023
The biomedical giant best known for its Cologuard at-home colon cancer screening test reported third-quarter net income of $0.8 million, or $0.00 per share, on revenue of $628 million.
November 3, 2023
Genialis, the RNA-biomarker company, today announced new data detailing how RNA sequencing data can help elucidate tumor biologies that may be amenable to immunotherapies and targeted agents. The information was presented in two posters at the...
November 3, 2023
The biomedical giant best known for its Cologuard at-home colon cancer screening test reported third-quarter net income of $0.8 million, or $0.00 per share, on revenue of $628 million.
November 2, 2023
EXAS earnings call for the period ending September 30, 2023.
November 1, 2023
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...
November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
November 1, 2023
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings.
November 1, 2023
Exact Sciences, a large Cathie Wood's holding, came in hot with double-digit sales growth. The results could prod EXAS stock. The post Exact Sciences, A…
October 31, 2023
How do you define a stock market opportunity? Is it a windfall, a piece of luck, or the result of careful planning, a strategy to make the most of any opening? The savvy investor seeks out the latter, looking for stocks that offer inducements to entry, be it a high upside or a depressed share price or a recent positive analyst review – or better yet, a combination of all three. So there’s a profile. We’ve used the TipRanks database to look up two stocks that fit it – ...
October 31, 2023
Banque Pictet & Cie SA lifted its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 295,013 shares of the medical research company’s stock after purchasing an additional 2,287 shares […]